Profiling of Polyphenolic Compounds of Leontopodium alpinum Cass Callus Cultures Using UPLC/IM-HRMS and Screening of In Vitro Effects.
Ioana-Ecaterina PraleaRadu Cristian MoldovanAdrian-Bogdan ȚiguAlina-Maria PetracheSimona Codruta HeghesMonica Elena MitoiGina CogălniceanuCristina-Adela IugaPublished in: Plants (Basel, Switzerland) (2021)
Leontopodium alpinum Cass. (edelweiss) is recognized as a frequent constituent of anti-aging skin care products, providing increased antioxidant and anti-inflammatory defense. Considering the growing demand and the protected status of edelweiss in many countries, alternative methods of production have been developed, one of them being callus culturing. This study reports the phytochemical composition of a methanolic extract of L. alpinum callus cultures, characterized by liquid chromatography coupled to ion-mobility high resolution mass spectrometry (UPLC/IM-HRMS). The methanolic extract exhibited strong free radical scavenging activity (122.19 ± 7.28 mg AAE/g dw), while the quantitative evaluation revealed that four major constituents (phenylpropanoid derivatives) represent 57.13% (m/m) of the extract. Consequently, a screening of antiproliferative effects was performed on ten cancer cell lines, representative of prostate, colon, lung and breast cancer, showing inhibition of colony formation in all cases. These results provide a comprehensive phytochemical characterization of L. alpinum callus cultures using advanced IM-HRMS, while the in vitro explorations confirmed the potent antioxidant properties of edelweiss which are worth exploring further in cancer prevention.
Keyphrases
- high resolution mass spectrometry
- anti inflammatory
- liquid chromatography
- ultra high performance liquid chromatography
- mass spectrometry
- simultaneous determination
- oxidative stress
- papillary thyroid
- tandem mass spectrometry
- gas chromatography
- prostate cancer
- healthcare
- squamous cell
- solid phase extraction
- squamous cell carcinoma
- palliative care
- young adults
- quality improvement
- childhood cancer
- pain management
- adverse drug
- emergency department